Clinical Trials Browser

Phase 2 × Liver Neoplasms × Hepatectomy × Clear all

NCT05471674 2023-02-01

Neoadjuvant Anti-PD1 in HCC

Phase 2 Completed

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms